DAWN

DAWN

USD

Day One Biopharmaceuticals Inc. Common Stock

$7.300+0.040 (0.551%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$7.260

Haut

$7.490

Bas

$7.108

Volume

10.46M

Fondamentaux de l'Entreprise

Capitalisation Boursière

747.8M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.49M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $5.635Actuel $7.300Haut $16.76

Actualités Connexes

GlobeNewswire

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core business Raising OJEMDA full-year 2025 net product revenue guidance to $145 to $150 million Three-year FIREFLY-1 data

Voir plus
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
GlobeNewswire

Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025

BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (NASDAQ:DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for

Voir plus
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025